A fermented ginseng extract, BST204, inhibits proliferation and motility of human colon cancer cells

Biomolecules and Therapeutics

Volumn 19, Issue 2, 2011, Pages 211-217

  Park, Jong Woo ^a   Lee, Jae Cheol ^a   Ann, Sora ^a   Seo, Dong Wan ^b   Choi, Wahn Soo ^c   Yoo, Young Hyo ^d   Park, Sun Kyu ^d   Young, Jung ^d   Um, Sung Hee ^a   Ahn, Seong Hoon ^e   Han, Jeung Whan ^a  

^a Sungkyunkwan University   (South Korea)

^b Kangwon National University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Green Cross Herb and Pharmaceutical Co Ltd   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

BST204; Cell cycle; Cell migration; Cell proliferation; Colon cancer; Ginsenoside

Indexed keywords

BST 204; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; GINSENG EXTRACT; GINSENOSIDE RH 2; METALLOPROTEINASE; METALLOPROTEINASE 9; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FERMENTATION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ARALIACEAE; PANAX GINSENG;

EID: 79956124708     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2011.19.2.211     Document Type: Article

References (46)

1. Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R. and Owens, D. M. (2002) Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene. 21, 4728-4738.
2. Attele, A. S., Wu, J. A. and Yuan, C. S. (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58, 1685-1693.
3. Bocca, C., Bozzo, F., Cannito, S., Colombatto, S. and Miglietta, A. (2009) CLA reduces breast cancer cell growth and invasion through ERalpha and PI3K/Akt pathways. Chem. Biol. Interact. 186, 250-251.
4. Bourguignon, L. Y., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J., Muller, W. J. and Cardiff, R. D. (1998) CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol. 176, 206-215.
5. Cheng, C. C., Yang, S. M., Huang, C. Y., Chen, J. C., Chang, W. M. and Hsu, S. L. (2005) Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol. 55, 531-540.
6. Cho, H. J., Kang, J. H., Kwak, J. Y., Lee, T. S., Lee, I. S., Park, N. G., Nakajima, H., Magae, J. and Chang, Y. C. (2007). Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis. 28, 1104-1110.
7. Choi, S., Kim, T. W. and Singh, S. V. (2009) Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent Inhibition of cyclindependent kinases. Pharm. Res. 26, 2280-2288.
8. Chou Chou, C. C. and Hsu, C. Y. (2009) Involvement of PKC in TPApotentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells. Naunyn. Schmiedebergs Arch. Pharmacol. 379, 1-9.
9. el-Deiry, W. S, Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell. 75, 817-825
10. Eun, D. W., Ahn, S. H., You, J. S., Park, J. W., Lee, E. K., Lee, H. N., Kang, G. M., Lee, J. C., Choi, W. S., Seo, D. W. and Han, J. W. (2007) PKCepsilon is essential for gelsolin expression by histone deacetylase inhibitor apicidin in human cervix cancer cells. Biochem. Biophys. Res. Commun. 354, 769-775.
11. Fei, X. F., Wang, B. X., Tashiro, S., Li, T. J., Ma, J. S. and Ikejima, T. (2002) Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta. Pharmacol. Sin. 23, 315-322.
12. Gartel, A. L. and Tyner, A. L. (1999) Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp. Cell Res. 246, 280-289.
13. Grutter, M. G. (2000) Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol. 10, 649-655.
14. Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G. U., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y. W. and Lee, H. W. (2000) Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 60, 6068-6074
15. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75, 805-816.
16. Jackson, J. G. and Pereira-Smith, O. M. (2006) Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol. Cell Biol. 26, 2501-2510.
17. Jin, Y. H., Yoo, K. J., Lee, Y. H. and Lee, S. K. (2000) Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin Acyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J. Biol. Chem. 275, 30256-30263.
18. Johnson, G. L. and Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
19. Kim, S., Kang, J. K., Kim, Y. K., Seo, D. W., Ahn, S. H., Lee, J. C., Lee, C. H., You, J. S., Cho, E. J., Lee, H. W. and Han, J. W. (2006a) Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. Biochem. Biophys. Res. Commun. 342, 1168-1173.
20. Kim, S. Y., Kim, D. H., Han, S. J., Hyun, J. W. and Kim, H. S. (2007) Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Biochem. Pharmacol. 74, 1642-1651.
21. Kim, W. Y., Kim, J. M., Han, S. B., Lee, S. K., Kim, N. D., Park, M. K., Kim, C. K. and Park, J. H. (2000) Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63, 1702-1704.
22. Kim, Y. K., Lee, E. K., Kang, J. K., Kim, J. A., You, J. S., Park, J. H., Seo, D. W., Hwang, J. W., Kim, S. N., Lee, H. Y., Lee, H. W. and Han, J. W. (2006b) Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis. Cell Death Differ. 13, 2033-2041.
23. Kitts, D. D., Wijewickreme, A. N. and Hu, C. (2000) Antioxidant properties of a North American ginseng extract. Mol. Cell Biochem. 203, 1-10.
24. Kumar, A., Kumar, M., Park, T. Y., Park, M. H., Takemoto, T., Terado, T., Kitano, M. and Kimura, H. (2009) Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis. Int. J. Mol. Med. 24, 381-386
25. Kwon, S. H., Ahn, S. H., Kim, Y. K., Bae, G. U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y. W., Lee, H. W. and Han, J. W. (2002) Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J. Biol. Chem. 277, 2073-2080.
26. Lee, K. Y., Park, J. A., Chung, E., Lee, Y. H., Kim, S. I. and Lee, S. K. (1996) Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett. 110, 193-200.
27. Liu, T. G, Huang, Y., Cui, D. D., Huang, X. B., Mao, S. H., Ji, L. L., Song, H. B. and Yi, C. (2009) Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer. 9, 250.
28. Maekawa, R., Maki, H., Yoshida, H., Hojo, K., Tanaka, H., Wada, T., Uchida, N., Takeda, Y., Kasai, H., Okamoto, H., Tsuzuki, H., Kambayashi, Y., Watanabe, F., Kawada, K., Toda, K., Ohtani, M., Sugita, K. and Yoshioka, T. (1999) Correlation of antiangiogenic and antitumor effi cacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res. 59, 1231-1235.
29. Mehendale, S. R., Wang, C. Z., Shao, Z. H., Li, C. Q., Xie, J. T., Aung, H. H. and Yuan, C. S. (2006) Chronic pretreatment with American ginseng berry and its polyphenolic constituents attenuate oxidant stress in cardiomyocytes. Eur. J. Pharmacol. 553, 209-214
30. Mittnacht, S. (1998) Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8, 21-27.
31. Nakata, H., Kikuchi, Y., Tode, T., Hirata, J., Kita, T., Ishii, K., Kudoh, K., Nagata, I. and Shinomiya, N. (1998) Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 89, 733-740.
32. Nishimoto, S. and Nishida, E. (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 7, 782-786.
33. Oh, J. I., Chun, K. H., Joo, S. H., Oh, Y. T. and Lee, S. K. (2005) Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells. Cancer Lett. 230, 228-238.
34. Park, J. A., Lee, K. Y., Oh, Y. J., Kim, K. W. and Lee, S. K. (1997) Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett. 121, 73-81.
35. Popovich, D. G. and Kitts, D. D. (2002) Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem Biophys. 406, 1-8.
36. Rosenblum, G., Meroueh, S. O., Kleifeld, O., Brown, S., Singson, S. P., Fridman, R., Mobashery, S. and Sagi, I. (2003) Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J. Biol. Chem. 278, 27009-27015.
37. Saya, H. Molecular mechanism regulating effect of anti-cancer agents. (2009) Gan To Kagaku Ryoho. 36, 1-5.
38. Seo, J. Y., Lee, J. H., Kim, N. W., Her, E., Chang, S. H., Ko, N. Y., Yoo, Y. H., Kim, J. W., Seo, D. W., Han, J. W., Kim, Y. M. and Choi, W. S. (2005a). Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. Int. Immunopharmacol. 5, 929-936.
39. Seo, J. Y., Lee, J. H., Kim, N. W., Kim, Y. J., Chang, S. H., Ko, N. Y., Her, E., Yoo, Y. H., Kim, J. W., Lee, B. Y., Lee, H. Y., Kim, Y. M. and Choi, W. S. (2005b) Inhibitory effects of a fermented ginseng extract, BST204, on the expression of inducible nitric oxide synthase and nitric oxide production in lipopolysaccharide-activated murine macrophages. J. Pharm. Pharmacol. 57, 911-918.
40. Shamamian, P., Schwartz, J. D., Pocock, B. J., Monea, S., Whiting, D., Marcus, S. G. and Mignatti, P. (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for infl ammatory cells in tumor invasion and angiogenesis. J. Cell Physiol. 189, 197-206.
41. Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, Y., Kakizaki, A. and Takahashi, E. (1999) Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol. 369, 23-32.
42. Tanno, S., Tanno, S., Mitsuuchi, Y., Altomare, D. A., Xiao, G. H. and Testa, J. R. (2001) AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res. 61, 589-593.
43. Ura, H., Bonfi l, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C. and Klein-Szanto, A. J. (1989) Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 49, 4615-4621.
44. Wang, C. Z., Zhang, B., Song, W. X., Wang, A., Ni, M., Luo, X., Aung, H. H., Xie, J. T., Tong, R., He, T. C. and Yuan, C. S. (2006) Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J. Agric. Food Chem. 54, 9936-9942.
45. Wu, Q., Liu, S., Ding, L., Ye, X. and Su, W. (2002) PKCalpha translocation from mitochondria to nucleus is closely related to induction of apoptosis in gastric cancer cells. Sci. China. C. Life. Sci. 45, 237-244.
46. Yun, T. K. (2003) Experimental and epidemiological evidence on nonorgan specifi c cancer preventive effect of Korean ginseng and identifi cation of active compounds. Mutat. Res. 523, 63-74.